Schilling FH - Search Results

1

Somatostatin in neuroblastoma and ganglioneuroma.

Kogner P, Borgström P, Bjellerup P, Schilling FH, Refai E, Jonsson C, Dominici C, Wassberg E, Bihl H, Jacobsson H, Theodorsson E, Hassan M. Kogner P, et al. Among authors: schilling fh. Eur J Cancer. 1997 Oct;33(12):2084-9. doi: 10.1016/s0959-8049(97)00212-8. Eur J Cancer. 1997. PMID: 9516858

2

Coexpression of mRNA for the full-length neurotrophin receptor trk-C and trk-A in favourable neuroblastoma.

Svensson T, Rydén M, Schilling FH, Dominici C, Sehgal R, Ibáñez CF, Kogner P. Svensson T, et al. Among authors: schilling fh. Eur J Cancer. 1997 Oct;33(12):2058-63. doi: 10.1016/s0959-8049(97)00290-6. Eur J Cancer. 1997. PMID: 9580079

3

Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favourable tumour stage and good prognosis.

Rydén M, Sehgal R, Dominici C, Schilling FH, Ibáñez CF, Kogner P. Rydén M, et al. Among authors: schilling fh. Br J Cancer. 1996 Sep;74(5):773-9. doi: 10.1038/bjc.1996.435. Br J Cancer. 1996. PMID: 8795581 Free PMC article.

4

Somatostatin receptor scintigraphy (SRS): a new diagnostic tool in neuroblastoma (NB)?

Dörr U, Sautter-Bihl ML, Schilling FH, Koscielniak E, Treuner J, Bihl H. Dörr U, et al. Among authors: schilling fh. Prog Clin Biol Res. 1994;385:355-61. Prog Clin Biol Res. 1994. PMID: 7972231 No abstract available.

5

Combined (111)In-pentetreotide scintigraphy and (123)I-mIBG scintigraphy in neuroblastoma provides prognostic information.

Schilling FH, Bihl H, Jacobsson H, Ambros PF, Martinsson T, Borgström P, Schwarz K, Ambros IM, Treuner J, Kogner P. Schilling FH, et al. Med Pediatr Oncol. 2000 Dec;35(6):688-91. doi: 10.1002/1096-911x(20001201)35:6<688::aid-mpo44>3.0.co;2-7. Med Pediatr Oncol. 2000. PMID: 11107147

6

Absence of somatostatin receptor expression in vivo is correlated to di- or tetraploid 1p36-deleted neuroblastomas.

Schilling FH, Ambros PF, Bihl H, Martinsson T, Ambros IM, Borgström P, Jacobsson H, Falkmer UG, Treuner J, Kogner P. Schilling FH, et al. Med Pediatr Oncol. 2001 Jan;36(1):56-60. doi: 10.1002/1096-911X(20010101)36:1<56::AID-MPO1015>3.0.CO;2-1. Med Pediatr Oncol. 2001. PMID: 11464907

7

Somatostatin receptor imaging: a new horizon in the diagnostic management of neuroblastoma.

Sautter-Bihl ML, Dörr U, Schilling F, Treuner J, Bihl H. Sautter-Bihl ML, et al. Semin Oncol. 1994 Oct;21(5 Suppl 13):38-41. Semin Oncol. 1994. PMID: 7992079 No abstract available.

8

Evidence of chromaffin oxygen sensing in neuroblastoma.

Hedborg F, Franklin G, Norrman J, Grimelius L, Wassberg E, Hero B, Schilling F, Berthold F, Harms D, Sandstedt B. Hedborg F, et al. Med Pediatr Oncol. 2001 Jan;36(1):149-53. doi: 10.1002/1096-911X(20010101)36:1<149::AID-MPO1036>3.0.CO;2-M. Med Pediatr Oncol. 2001. PMID: 11464871

9

Evidence for hypoxia-induced neuronal-to-chromaffin metaplasia in neuroblastoma.

Hedborg F, Ullerås E, Grimelius L, Wassberg E, Maxwell PH, Hero B, Berthold F, Schilling F, Harms D, Sandstedt B, Franklin G. Hedborg F, et al. FASEB J. 2003 Apr;17(6):598-609. doi: 10.1096/fj.02-0390com. FASEB J. 2003. PMID: 12665472

10

10 years' neuroblastoma screening in Europe: preliminary results of a clinical and biological review from the Study Group for Evaluation of Neuroblastoma Screening in Europe (SENSE).

Erttmann R, Tafese T, Berthold F, Kerbl R, Mann J, Parker L, Schilling F, Ambros P, Christiansen H, Favrot M, Kabisch H, Hero B, Philip T. Erttmann R, et al. Eur J Cancer. 1998 Aug;34(9):1391-7. doi: 10.1016/s0959-8049(98)00135-x. Eur J Cancer. 1998. PMID: 9849422

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters